Press play above for something supernatural from Bonython. *** Don't miss another headline from SURFER! Subscribe to our newsletter, follow us on Instagram, and stay connected with the latest ...
(RTTNews) - Shares of Supernus Pharmaceuticals Inc. (SUPN) are down over 20% in premarket trading Wednesday, following disappointing results from a Phase 2b study of SPN-820 in adults with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback